Home › Funds › Darwin Global Management, Ltd. › GMAB
Darwin Global Management, Ltd. position in GMAB
GENMAB A/S · Health Care
Darwin Global Management, Ltd. reported holding 17,899,876 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$638.6M, representing 16.00% of its reported portfolio and ranking #2 among its reported holdings. Darwin Global Management, Ltd. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Darwin Global Management, Ltd.'s GMAB position evolved
Darwin Global Management, Ltd. first disclosed a stake in GMAB in Q3 2026 at 17,899,876 shares (US$638.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 17.90M | $638.58M | New |
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 35 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$504.3M), Orbis Allan Gray Ltd (US$377.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$244.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 14.14M sh · $504.32M · Q3 2026
- Orbis Allan Gray Ltd 10.57M sh · $376.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $244.91M · Q3 2026
- Sofinnova Investments, Inc. 4.35M sh · $155.17M · Q3 2026
- HARDING LOEVNER LP 2.90M sh · $134.23M · Q3 2026
- Point72 Asset Management 3.54M sh · $126.11M · Q3 2026
- Deep Track Capital, LP 2.76M sh · $98.46M · Q3 2026
- GREAT POINT PARTNERS LLC 525.00K sh · $18.73M · Q3 2026
- DIADEMA PARTNERS LP 518.10K sh · $18.48M · Q3 2026
More on Darwin Global Management, Ltd.
FAQ
How long has Darwin Global Management, Ltd. held GMAB?
Darwin Global Management, Ltd. has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Darwin Global Management, Ltd.'s current position in GMAB?
As of Q3 2026, Darwin Global Management, Ltd. holds 17.90M shares of GMAB (GENMAB A/S), valued at $638.58M, representing 16.00% of its reported portfolio and ranking #2.
Has Darwin Global Management, Ltd. been buying or selling GMAB?
In the latest 13F filing (Q3 2026), Darwin Global Management, Ltd. newly opened its position in GMAB.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.